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Abstract: Ultrasound-assisted crystallization (sonocrystallization) 
was used to prepare a mixture of nano- and micrometer-sized 
crystals of the monoclinic form of paracetamol − a widely used 
analgesic known for its particularly problematic mechanical behavior 
under compression (i.e. poor tabletability). The nano- and micro-
sized crystals yielded a powder which exhibits elastic moduli and 
bulk cohesions that are significantly higher than those observed in 
samples consisting of macro-sized crystals, thus leading to 
enhanced tabletability without the use of excipients, particle coating, 
salt- or cocrystal formation. Experimental compaction and finite 
element analysis were utilized to rationalize the significantly 
improved compaction behavior of the monoclinic form of 
paracetamol. 
The current demand for organic nanomaterials[1-3] has 
triggered the development of fabrication methods for organic 
nanocrystals based on single[4-10] and multiple components (i.e. 
cocrystals).[11-14] Recent pharmaceutical and biomedical 
research has shown that molecular nanocrystals are highly 
valuable in the context of drug delivery, biolabeling and 
biosensing.[15-19] Nano-sizing of molecular crystals has also 
become a particularly popular approach in drug development of 
poorly soluble pharmaceutical agents[20] and is mainly used to 
enhance the solubility and bioavailability of the drug 
candidate.[21-23] Surprisingly, other applications of molecular 
crystals, despite their unique physicochemical properties, have 
been relatively unexplored in biomedical (and other) sciences. 
We show in this contribution that nano-sized crystals can 
significantly improve the mechanical properties of a crystalline 
pharmaceutical agent via sonocrystallization,[24-26] i.e. the use of 
ultrasound to facilitate crystallization.[27-28]  
Paracetamol (pca, Fig. 1), also known as acetaminophen, is 
an exceptionally popular analgesic and antipyretic that achieves 
annual sales of more than 1 billion USD in the United States 
alone.[29] Pca exhibits two well-known polymorphs – the 
monoclinic[30] form I and the orthorhombic[31] form II. An elusive 
and metastable polymorph, form III, has only recently been 
structurally characterized.[32] The thermodynamically stable form 
I exhibits poor tabletability under compression.[33-35] The 
orthorhombic form II, on the other hand, displays significantly 
better compaction properties,[33, 36] but is thermodynamically less 
stable[37-38] and, thus, not ideal for drug formulation and 
commercialization. The poor tabletability of form I is attributed to 
its crystal structure. In particular, form I is based on corrugated 
hydrogen-bonded layers of pca molecules and lacks the 
presence of flat molecular layers that can promote the formation 
of microscopic slip planes capable of rendering the crystalline 
solid plastic and easier to compact (Fig. 1a).[33] Form II, on the 
other hand, exhibits slip planes comprised of flat hydrogen-
bonded pca layers[31] that promote better  tabletability (Fig. 1b).  
Pca is generally formulated using the poorly compactible 
monoclinic form I along with up to 25 wt% of excipients to 
reduce occurrence of defective tablets, such as capping, 
lamination or chipping.[39] The poorly compactible crystals of 
from I can also be coated with hydroxypropyl cellulose to 
improve their behavior under compression.[40] Alternatively, pca 
can be formulated as a salt[41] or cocrystal[42-43] in order to 
facilitate the assembly of crystal structures that contain slip 
planes that result in improved tabletability. 
Figure 1. Chemical structure of pca (top) and the crystal structures of a) form I 
(monoclinic, stable) and b) form II (orthorhombic, metastable) featuring 
corrugated and flat molecular sheets found in their respective crystal 
structures. 
A recent study has shown that freeze-drying of water-
acetone solutions of pca leads to the formation of micro-
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Figure 2. Crystallographic characterization of the sonocrystallized bulk of form I: a) PXRD patterns of pca (black – calculated form I, red – sonocrystallized form I, 
orange – sonocrystallized form I after compaction, grey – calculated form II) and b,c) SAED patterns obtained from individual nano-dimensional single crystals are 
consistent with the formation of form I (b: <010> zone axis, c: <21-1> zone axis). The SEM and TEM images shown in d, e and f-h (respectively) depict 
sonocrystallized nano- and micro-particles of form I exhibiting broad particle size distributions. The green and red circles in micrograph (f) highlight nanocrystalline 
plates with a measured thickness of 220-230 nm (green) and 470-590 nm (red). 
crystals of form I with enhanced compaction properties.[44] 
Specifically, it was demonstrated that tablets based on 
submicrometer-sized crystals exhibit a high compressive 
strength of 40 MPa (axially) and about 6 MPa (diametrally), as 
well as a low porosity of 6%. Such tablets, however, need to be 
prepared using a compaction pressure of 345 MPa – which 
exceeds those typically used in industrial tableting processes (i.e. 
in the range of 100-150 MPa) to limit damage to dies and 
tooling.[45] Furthermore, it was suggested that the freeze-drying 
method is not economically viable for inexpensive drugs such as 
pca.[44]   
We show in this article that time- and cost-efficient 
ultrasound-assisted crystallization yields submicrometer- and 
micrometer-sized crystals of form I, which were shown to exhibit 
elastic moduli and bulk cohesions that are significantly higher 
than those observed in macrocrystalline form I, giving rise to a 
remarkable increase in tabletability at compaction pressures that 
are typically used in current industrial processes. We also reveal 
that mechanochemically prepared nano-crystals (using liquid-
assisted grinding as a production method) exhibit narrower 
particle size distributions and are not as tabletable as the 
sonocrystallized solid, thus suggesting that particle size 
distribution possibly plays a significant role in the improvement 
of the compaction behavior of form I. 
Combined sonication and fast precipitation afforded the 
formation of a physical mixture of nano- and micro-crystals of 
form I. In a typical sonocrystallization experiment, pca was 
dissolved in a minimal amount of ethanol to obtain a solution 
that was immediately injected through a syringe filter into 
hexane while exposed to ultrasound. The suspension was 
sonicated for 1 min, filtered and dried at room temperature. The 
obtained solid was analyzed by X-ray powder diffraction (PXRD), 
selected area electron diffraction (SAED), scanning-electron 
microscopy (SEM) and transmission electron microscopy (TEM). 
Details of the synthesis and analysis are provided in the 
Supporting Information (SI) document.   
A PXRD analysis of the bulk material, in addition to SAED 
measurements of individual nanocrystals, revealed that pca 
crystallizes as form I (Fig. 2a-c). The presence of the 
orthorhombic form II could not be detected via PXRD and SAED. 
A thorough inspection of the SEM and TEM micrographs 
indicated that the sonocrystallized sample exhibits a broad 
particle-size distribution. Specifically, the micrographs revealed 
the presence of aggregated nano- and micrometer-sized crystals 
with plate and prism morphologies and prism in the bulk (Fig. 
2d-h, and Fig. S3-S6 in the SI document). The micrographs also 
showed that the crystals are uniform in shape, with particle sizes 
ranging from ~0.14 µm to ~40 µm in length. The thickness of the 
crystal plates was estimated based on TEM images and to be as 
low as ~200 nm. A particle-size distribution analysis was 
attempted using dynamic light scattering (DLS) and powder X-
ray diffraction (PXRD). The DLS results indicated that the nano- 
and microcrystals form aggregates with an average diameter of 
60 µm. Although crystal agglomeration can be prevented by the 
use of surfactants, we have not considered the use of 
surfactants to characterize the sonocrystallized solid, as they are 
known to alter crystal size and morphology.[46] The PXRD data 
did not reveal any measurable peak broadening that could be 
attributed o the presence of nanocrystals in the bulk. This 
observation is consistent with the sample’s broad particle-size 
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Figure 3. a) Comparison of stress-density curves for macrocrystalline (black), sonocrystallised (red), mechanochemically prepared (dotted green) form I. Relative 
density refers to the powder density relative to the density of the crystal structure of form I (ρ = 1.263 g cm−3) (inset: tablets composed of commercial and 
sonocrystallized form I after compaction); b,c) TEM micrographs showing that the compacted nano- and microcrystals of form I shattered into smaller particles; 
d,e) SAED patterns obtained from individual nano-dimensional compacted single crystals reveal that compaction has lead to an increase in crystal defect, but no 
phase transition; f,g) stress distributions calculated from axisymmetric finite element simulations of cylindrical tablets comprised of macrocrystalline form I and 
nanocrystalline  form I during ejection from die (the top of die wall is indicated by a horizontal white line on far right-hand side of the figures, and left-hand side is 
the axis of die, about which the simulation is cylindrically symmetrical). 
distribution and the presence of micrometer-sized crystals in the 
sonocrystallized bulk material.  
To evaluate the compaction behavior of commercial (i.e. 
macrocrystalline) and sonochemically (i.e. nano-/micro-
crystalline) prepared batches of form I, we utilized a hydraulic 
uniaxial compaction simulator with an instrumented die (Huxley 
Bertram), allowing simultaneous measurement of axial and 
radial stresses and, ultimately, stress-density curves for the 
studied materials. Relevant parameters relating to the 
mechanical properties of the solids are shown in Table 1, 
wherein they are also compared to those of Avicel® PH101 (a 
pharmaceutical-grade microcrystalline cellulose commonly used 
as binder to hold the ingredients in a tablet together). 
 
Table 1. Material parameters for powders characterized by compaction 
simulator using DPC constitutive model. 
material 
Young’s modulus  
(E / MPa) 
cohesion  
(d / MPa) 
Avicel® (PH101) 3700 4.2 
pca (commercial) 2612 0.1 
pca (sonocrystallized) 6365 3.4 
 
As expected, it was observed that tablets formed from the 
commercial pca sample crumbled on ejection from the die.[33-35] 
In contrast, the tablets made from sonocrystallized pca retained 
their sharp edges (Fig. 3a, inset). A comparison of the stress-
density curves for sonocrystallized and commercial pca is 
shown in Fig. 3a. It can be seen that, during unloading phase, 
the sonocrystallized form I obtained a higher relative density 
than the macrocrystalline form at the same applied pressure, 
indicating that more plastic deformation had taken place. The 
final relative densities of tablets after ejection from die were 
0.922 (7.8% porosity) and 0.866 (13.4% porosity), respectively, 
indicating that the tablet formed from sonocrystallized material is 
more than 40% less porous than the tablet formed from 
macrocrystalline powder under same conditions.  
Compaction simulations using the Drucker-Prager cap 
constitutive model[47-48] revealed that particles of sonocrystallized 
form I exhibit higher elastic moduli than the macrocrystalline one 
(Table 1). The higher elastic modulus suggests that 
sonocrystallized form I should have an inferior ability to 
plastically deform, thus leading to poor compaction properties. 
The improved tabletability of sonocrystallized form I is, however, 
attributed to its greater compactability (i.e. higher relative density 
under given load) and the greater amount of plastic work 
dissipated during compaction. Both of these effects feasibly 
arise indirectly from the nano-sized particles that exhibit a 
greater total contact area between particles thus increasing their 
cohesion and packing density compared to macrocrystalline 
sample. Despite an apparent increase in elastic modulus of the 
sonocrystallized form I relative to macrocrystalline form (by a 
factor of 2.4, see Table 1), the vastly increased cohesion (by a 
factor of 34, see Table 1) and extra plastic work during 
deformation mean that tablet fracture due to elastic recovery on 
decompression is less likely in the tablet made from 
sonocrystallized powder.  
A TEM study on the tableted powder of the sonocrystallized 
batch of form I was also carried out to determine whether a 
polymorphic phase transition has occurred that could lead to the 
improved compaction behavior. For this purpose, we halved a 
tablet, and investigated only the solid that “crumbled” off the 
halved tablet and has, thus, not been in contact with the utilized 
tools. A PXRD measurement showed that the solid still consists 
exclusively of form I crystals (Fig. 2a). In addition, TEM 
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micrographs (Fig. 3b-e) showed that the investigated crystals 
correspond to form I. The observed crystals are considerably 
smaller in size (i.e. ~ 1 µm along all crystal axes) (Fig. 3b,c), 
thus indicating that the nano- and microcrystals cracked into 
smaller particles during the compaction process. This is further 
evidenced by SAED experiments that revealed that the crystals 
exhibited a significantly higher degree of mosaicity (Fig. 3d,e), 
as compared to those prior to compaction. Moreover, a PXRD 
trace of the compacted material revealed broadening of the 
diffraction peaks that is consistent with a decrease of the 
material’s particle size (average particle-size: ~1.5 µm, see SI 
document). 
To assess the behavior of pca under high pressure, 
axisymmetric finite element simulations of cylindrical tablets 
during ejection from die were used to calculate the stress 
distributions (Mises deviatoric stress, in MPa) within the 
compacted commercial and sonocrystallized solid. Figures 3f 
and 3g show the stress distribution for commercial (i.e. 
macrocrystalline) and sonocrystallized (i.e. nano-/micro-sized) 
pca at the same point during simulation, and shows that the 
stress distribution is more anisotropic for the commercial solid, 
especially near the edges of the tablet. Based on previous 
findings for tableting simulations using pharmaceutical 
excipients,[47] this would suggest that tablets made from 
macrocrystalline pca would be more likely to chip or fail 
mechanically during the ejection phase. 
The above-described results raised the question of whether 
the mechanical properties of form I can be further improved by 
preparing even smaller crystals that are also uniform in size. To 
evaluate this possibility, we turned to liquid-assisted grinding[49-
50] - a mechanochemical method used to generate high-shear 
and impact forces for the making of uniform nano-dimensional 
crystals.[51] In a typical experiment, a macro-crystalline batch of 
form I was milled in the presence of hexane. PXRD was used to 
identify the milled pca sample as form I, while PXRD and SEM 
were used to define the sample as nano-crystalline and more 
uniform (as compared to sonocrystallized pca) with an average 
particle size of 1 µm. Details of the PXRD particle-size analyses 
are provided in the SI document.  
The compaction studies showed that tablets made from 
milled pca crumbled on ejection from the die, as seen in the 
case of commercial pca (see the SI document). Similarly to the 
sonocrystallized solid, the milled material consisted exclusively 
of form I crystals that have decreased in size upon exposure to 
the high pressures (average particle size: 0.9 µm, see SI 
document). Furthermore, the stress-density curve of the milled 
sample exhibited a relative density of 0.891 (10.9% porosity), 
which is higher than that of the commercial sample (0.866, 
13.4% porosity), but lower than that of sonocrystallized pca 
(0.922, 7.8% porosity). It is interesting to compare the behavior 
of the sonocrystallized and milled samples, both of which 
contain appreciable amounts of nano-sized crystals (Fig. 2 and 
3; also, see the SI document). Despite this similarity, Figure 3 
shows that the load curve for milled form I (dotted green line) 
differs significantly from both macrocrystalline and 
sonocrystallized samples (black and red, respectively). In 
particular, the sonocrystallized sample reaches a higher 
maximum relative density (i.e. lower porosity) for loads 
exceeding 40 MPa, and has a larger hysteresis on unloading, 
indicating a greater amount of mechanical work is lost to plastic 
deformation or fracture of particles on compaction. The 
increased propensity to plastic deformation of nano-sized 
crystals is known for metallic systems,[52] and may also be a 
contributing factor to the improved tabletability of the 
sonocrystallized and milled form I over the commercial 
macrocrystalline solid. The origin of the poorer compaction 
properties of the milled solid when compared to those of the 
sonocrystallized solid remains, at this point, to be fully 
understood. 
To conclude, we have shown that pca form I, an analgesic 
and antipyretic known for its poor tabletability, can be 
crystallized using a combination of ultrasonication and fast 
precipitation to obtain a mixture of nano- and macrocrystals that 
display significantly improved tabletability at pressures that are 
typically used in current industrial processes, and in the absence 
of any excipients. The superior tabletability is attributed to the 
solid’s enhanced ability to plastically deform and the cohesive 
interactions between its particles that are significantly higher 
than those observed in the macrocrystalline samples. We have 
also shown that milled form I (consisting of smaller uniform 
particles) displays compaction properties that are inferior to 
those observed for the sonocrystallized material, thus suggests 
the possibility that a broader particle size distribution promotes 
the tabletability of pca. We believe that the presented results 
demonstrate the utility of sonocrystallization in the preparation of 
pharmaceutically relevant molecular nano/macrocrystals with 
superior properties. Studies are underway to evaluate the impact 
of particle size and distribution on the mechanical properties of 
other organic solids obtained using bottom-up (e.g. 
sonocrystallization) and top-down (e.g. milling) methods. 
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